We found that IL-27 enhanced HIV-1 growth when added on the fourth day after infection (Fig. 4A) as observed from a time course assay (see Fig. S3), contrasting with the HIV-1 inhibition when added to infected PBMCs 2 h after infection. This evidence concerns the gene IL27 and infection.